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Dendritic Cells Permit Identification
of Genes Encoding MHC Class II±Restricted
Epitopes of Transplantation Antigens
demonstrate a more limited, mostly di-allelic, polymor-
phism. The peptides enter the biosynthetic pathway of
MHC molecules and are expressed at the cell surface
within the peptide binding groove of the MHC molecules
(Bjorkman et al., 1987a, 1987b), where they can be rec-
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Guy's, King's and St Thomas' Medical School Simpson and Chandler, 1997). To date, the major focus has
King's College been on CD81 clones to identify several class I±restricted
Thomas Guy House minor H epitopes. This is in part on the assumption that
Guy's Hospital CD81 cytotoxic cells are the main effector cells in graft
London SE1 9RT rejection but also because class I±restricted epitopes
United Kingdom have been relatively easy to express both in transfec-
tants (Scott et al., 1995; Mendoza et al., 1997) and by
peptide pulsing of APC (Rotzschke et al., 1990; den-
Haan et al., 1995). However, to understand the inductionSummary
phase of the response, when CD41 ªhelpº is required
to optimize generation of CD81 cells (Roopenian, 1992)Minor or histocompatibility (H) antigens are recog-
nized by CD41 and CD81 T lymphocytes as short poly- and since CD41 cells themselves can be effectors (Hung
morphic peptides associated with MHC molecules. et al., 1998), we have focused on ways of identifying the
They are the targets of graft versus host and graft MHC class II±restricted epitopes recognized by CD41
versus leukemia responses following bone marrow cells.
transplantation between HLA-identical siblings. Sev- There are significant differences in the way in which
eral genes encoding class I±restricted minor H epi- MHC class I and class II molecules become loaded with
topes have been identified, but approaches used for peptides for presentation to T cells. Peptides from en-
these have proved difficult to adapt for cloning class dogenously produced proteins are loaded into newly
II±restricted minor H genes. We have combined the synthesized class I molecules after translocation from
unique antigen-presenting properties of dendritic cells the cytoplasm into the endoplasmic reticulum (ER) via
and high levels of episomal expression following trans- the ATP-dependent peptide transporter (TAP) mole-
fection of COS cells to identify a Y chromosome gene cules (Neefjes et al., 1993). In contrast, the peptide load-
encoding two HY peptide epitopes, HYAb and HYEk. ing of class II molecules occurs in the endocytotic com-
partments (MIIC). Here, invariant chain (Ii) molecules
associated with class II molecules during biosynthesisIntroduction
are enzymically removed and replaced by peptides
(Cella et al., 1997). These can be derived either fromHistocompatibility (H) antigens are the products of poly-
exogenous proteins after endocytosis (Malcherek et al.,morphic genes recognized by the immune system fol-
1998) or from endogenously produced proteins in thelowing the exchange of organs or tissues between ge-
MIIC (Weiss and Bogen, 1991; Sanderson et al., 1995).netically dissimilar individuals. The MHC molecules
The distinction between class II±associated self-pep-themselves (HLA in humans, H2 in mice) are the most
tides loaded endogenously and those exogenously de-polymorphic, and exchange of tissues between individu-
rived is important and will influence the method chosenals expressing different MHC alleles causes rapid graft
to identify class II±restricted epitopes of cell-autono-rejection involving CD41 and CD81 lymphocytes and
mous origin, such as minor H antigens and tumor an-antibodies (Ting and Simpson, 1989). However, a vigor-
tigens.ous T cell response is still mounted even when donor and
recipient are MHC matched. This response is directed Efforts to transfect expression constructs containing
against minor H antigens. These are peptide products candidate minor H antigen genes into recipient APC
of ubiquitously expressed intracellular proteins that bearing the relevant MHC class II molecules have failed
to lead to detectable expression of class II±restricted
epitopes (data not shown). In model systems where§ To whom correspondence should be addressed (e-mail: elizabeth.
simpson@csc.mrc.ac.uk). genes or smaller fragments encoding peptide epitopes
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Figure 1. Schematic Representation of the
Mouse Y Chromosome
This shows the location of the Sxrb deletion
interval on the short arm, Yp, mouse Y chro-
mosome, and a transcription map of Sxrb. The
genes are represented by boxes: open for
nonfunctional genes, hatched for testis-spe-
cific, and black for ubiquitously expressed
genes. Their orientation is shown by the
arrows pointing toward the 39 end. The aster-
isks indicate genes whose X chromosome
homologs are known to escape X inactiva-
tion. Above is shown the extent of the deletion
in Abelson clone 87. The HY epitopes ex-
pressed by the genes are given below. Single
pound sign, HYDb epitope recognized by
clone CTL10 (Greenfield et al., 1996); double
pound sign, HYDb epitope recognized by
clone B6.2.16 (Markiewicz et al., 1998). The
two epitopes in bold are described in this
paper.
from, for example, influenza haemagglutinin (HA), oval- uitously expressed (Greenfield et al., 1996; Ehrmann et
al., 1998; Mazeyrat et al., 1998; Agulnik et al., 1999)bumen (OVA), hen egg lysozyme (HEL), or moth cyto-
chrome C (MCC) were transfected into APC, Ii was nec- (Figure 1) and have X chromosome homologs that for
the three genes that have been examined escape Xessary for optimal cell surface expression. Depending
on the experimental system, Ii was required either as a inactivation (Ehrmann et al., 1998; Greenfield et al., 1998;
Agulnik et al., 1999). The mouse gene Smcy encodescotransfection partner or as a fusion construct, using
the whole Ii molecule (for peptides) or its N-terminal three HY epitopes (HYKk, HYDk, and HYDb) (Scott et al.,
1995; Simpson et al., 1997; Markiewicz et al., 1998),lysosomal targeting sequence for loading peptides into
class II molecules expressed at the cell surface for sub- while Uty encodes the immunodominant HYDb epitope
(Greenfield et al., 1996). The human homolog SMCYsequent T cell recognition (Sanderson et al., 1995; Na-
kano et al., 1997). encodes the HLA-B7- (Wang et al., 1995) and -A2 (Mead-
ows et al., 1997)-restricted HY epitopes and UTY theIn this paper, we report results of experiments in which
constructs containing candidate Y chromosome genes, -B8 epitope (Warren et al., 1999). In attempts to identify
candidate genes for additional HY epitopes restrictedwith or without Ii sequences, have been transfected into
COS cells. We also describe the additional antigen-pro- by MHC class II molecules, we have focused on Smcy,
Uty, Dby, and Eif2gy.cessing step, using syngeneic female bone marrow
(BM)±derived dendritic cells, found necessary to obtain
expression of the MHC/HY peptide complexes for T cell Establishing a Protocol to Enable Detection
recognition. These results imply that the expression of of an H2Ab-Restricted Peptide Epitope
at least some minor H epitopes restricted by MHC class COS cells were transiently transfected with a construct
II molecules depends on reprocessing by professional containing the complete HEL sequence in pcDNA1. This
antigen-presenting cells. In vivo, this implies an impor- was transfected alone and cotransfected with Ii or as a
tant role for indirect presentation in generating CD41 fusion construct comprising the first 80 amino acids of
helper and effector T cells for rejection of transplants Ii and HEL (I80-HEL) (Sanderson et al., 1995) (Figure 2).
between MHC-matched individuals (Bevan, 1976). These HEL constructs were transfected with or without
the a and b chains of H2Ab, also in pcDNA1. Figure 3A
shows the results of testing the cells 48 hr after transfec-Results
tion for their ability to stimulate the H2Ab/HEL-specific
hybridoma B04H9.1. As expected, in the absence ofIdentification of Candidate Genes
All the genes that encode HY epitopes have been cotransfected H2Abab, none of the transfectants were
stimulatory. The I80-HEL COS 1 ab transfectants stimu-mapped to the Sxrb deletion interval on the short arm
of the mouse Y chromosome between Zfy1 and Zfy2 lated a good response directly, but COS 1 ab trans-
fected with HEL or Ii 1 HEL stimulated poorly or not at all(Simpson and Page, 1991; McLaren et al., 1984) (Figure
1). A panel of immunoselected radiation mutant clones (Figure 3A). The addition of day 6 bone marrow±derived
dendritic cells (DCs) from syngeneic female mice to thewith small deletions within this region showed that sev-
eral distinct genes were likely to encode different HY transfectants at 48 hr, followed by a further 24 hr incuba-
tion to allow reprocessing of the antigen expressed byepitopes. In particular, clone 87, with a deletion ex-
tending between and including eIF2gY and Dffry (M. J. M., the COS cell transfectants, resulted in even low num-
bers of the HEL COS 1 ab transfectants stimulating theunpublished data) does not express the HYDb and HYAb
epitopes (King et al., 1994). Within Sxrb, several genes hybridoma (Figure 3B). Addition of DCs did not signifi-
cantly increase the level of presentation by the I80-HELexhibit testis-specific expression, two are nonfunc-
tional, while four, Smcy, Uty, Dby, and eIF2gY, are ubiq- COS 1 ab transfectants. Interestingly, in the absence
MHC Class II±Restricted HY Epitopes Identified
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Figure 2. Schematic Representation of Ex-
pression Constructs of HEL and Dby
The wild-type (wt) murine Ii, p31 cDNA en-
codes a type II transmembrane protein of 215
residues. The region containing the class II±
associated Ii peptide (CLIP) is indicated. I80
constitutes the first 80 amino acids of Ii con-
taining an endosomal targeting sequence.
This fragment has been used to create fusion
proteins with HEL, Dby, and C-terminal Dby.
The HEL protein contains an Ab MHC class
II±restricted epitope at residues 74±91, indi-
cated by a shaded box. cDNAs encoding full-
length and truncated Dby fragments were
generated (see Experimental Procedures),
and the presence or absence of five potential
H2Ab binding motifs are indicated above each
construct, while the amino acid residues in-
cluded in each construct are shown below.
of cotransfected ab chains, none of the HEL constructs Requirements for Optimal Expression of a ªNaturalº
Endogenously Expressed Class II±Restricted Minorstimulated the hybridoma, even in the presence of BM
DCs. This suggests a crucial role for H2Ab ab in the H Antigen
COS cells were transfected with Dby in the presenceprotection of HEL peptides.
and absence of Ii and as an I80-fusion construct, with
and without H2Ab a and b and with and without added
Identification of the Gene Expressing MHC Class BM DCs. In the absence of dendritic cells, only the I80-
II±Restricted HY Epitopes Dby COS 1 ab transfectants stimulated the HYAb-spe-
Having established that reprocessing of HEL expressed cific T cell hybridoma (Figure 5A). In contrast, with BM
by COS 1 ab transfectants by BM DCs resulted in much DCs, maximal stimulation was given by COS cells trans-
higher expression of the H2Ab/HEL epitope, the candi- fected with Dby alone (Figure 5B). Cotransfection of Ii
date mouse Y chromosome genes were transfected into gave a slight reduction in the ability of the COS-Dby
transfectants to stimulate the hybridoma and, in con-COS cells, allowed to transiently express for 48 hr fol-
lowed by addition of female 6d BM DCs (H2b or H2k) for trast to the experiments using HEL as model antigen,
cotransfection of the H2Ab ab chains appeared to furthera further 24 hr. Figure 4 shows the results of screening
the transfectants for HY expression: Figure 4A, IL-2 pro- inhibit rather than enhance expression of the HYAb epi-
tope by the transfected cells. This may reflect quantita-duction by the HYAb-specific hybridoma and Figure 4B,
IFNg production by the HYEk-specific clone. Clearly, Dby tive differences in levels of Dby expression when several
genes are cotransfected simultaneously. These resultsexpresses both MHC class±II restricted Ab and Ek HY
epitopes. No stimulatory activity was detected in cells show naturally expressed MHC class II±restricted epi-
topes do not require H2Ab molecules to stabilize theirtransfected with Smcy, Uty, or Eif2gy.
Figure 3. Role of H2Ab a and b Chains and
Reprocessing by Female BM DCs in the Pre-
sentation of the H2Ab-HEL Epitope
IL-2 production by the HEL Ab hybridoma
stimulated by COS cell transfectants in the
absence (A) or presence (B) of d6 female BM
DCs.
(A) COS cells transfected with HEL (open cir-
cles, dotted line); HEL 1 Ii (open triangles);
I80-HEL (open boxes); HEL 1 ab (closed cir-
cles); HEL 1 Ii 1 ab (closed triangles); and
I80-HEL 1 ab (closed boxes).
(B) d6 female BM DCs plus COS cells trans-
fected as in (A). The results represent the
mean and SD of triplicate wells for each dilu-
tion of transfectant and are expressed as
dpm of an IL-2-responsive T cell clone. Con-
trol responses of the T cell clone to IL-2 and
medium alone are shown (open circles).
Immunity
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Figure 4. Stimulation of HYAb-Specific Hy-
bridoma and HYEk-Specific T Cell Clone by
COS Cells Transfected with Candidate Mouse
Y Chromosome Genes
(A) IL-2 production by the HYAb hybridoma
stimulated by COS cells transfected with Dby
(closed circles); Smcy (closed boxes); Uty
(open sqaures); and eIF2gY (closed triangles).
The transfectants were assayed in the pres-
ence of d6 C57BL/6 female BM DCs. Hybrid-
oma stimulation by control male and female
C57BL/6 splenocytes is indicated by open
circles. The results represent the mean and
SD of triplicate wells for each dilution and are
expressed as dpm of an IL-2-responsive T
cell clone.
(B) IFNg production by the HYEk T cell clone stimulated by COS cells transfected with Dby (closed circles); Smcy (closed boxes); Uty (open
boxes); eIF2gY (closed triangles). The transfectants were assayed in the presence of d6 CBA female BM DCs. Clone stimulation by control
male and female CBA splenocytes and medium alone is indicated by open circles. Results of screening of pooled supernatants by ELISA are
expressed as absorbance at 450 nm.
intracellular processing. The I80-Dby 1 ab fusion con- peptides bind equally to Ab (IC50 12 mM), implying that
both have the potential to be presented by H2Ab mole-structs gave similar stimulation in the presence or ab-
sence of BM DCs. cules. In addition, although nonstimulatory to our T cell
clone and hybridoma, peptide 4 (p4-Dby) showed strong
binding to H2Ab molecules (IC50 5 19 mM). The other
Identification and Properties of the HYAb peptides demonstrated moderate, weak, or no binding.
Peptide Epitope Substitution of serine (S) for asparagine (N) at position
To locate the HYAb epitope, pcDNA1 constructs com- 4 (assuming phenylalanine (F) in position 1 of the ªcoreº
prising the first 91 amino acids residues (N-terminal), peptide that occupies the MHC binding groove) resulted
residues1±504 (N 1 X), and the C-terminal residues in complete loss of T cell stimulatory activity (Figure 6C).
(591±630) of Dby (Figure 2) were transfected into COS Substitution of serine for asparagine at position 7 gave
cells, reprocessed by female BM DCs, and screened for negligible loss of activity.
HY expression. The C-terminal fragment expresses the
HYAb epitope (results not shown). Comparison of the
sequences of Dby with Dbx indicated five peptides with Identification of the HYEk Epitope
To locate the HYEk epitope, nine synthetic peptides ex-potential H2Ab binding motifs (Wall et al., 1994) in which
there is at least one amino acid difference between the pressing potential H2Ek binding motifs (Fremont et al.,
1996) and showing sequence differences between theX and the Y copy of the gene. These were synthesized
and tested with the HYAb clone. The results (Figure 6A) Dbx and Dby homologs were tested for their ability to
stimulate the HYEk clone. Figure 7 indicates that Dbyshow that only peptide 5 (p5-Dby-NAGFNSNRANSSRSS)
stimulated and at nanomolar concentrations. This is peptide 8, REEALHQFRSGRKPI, is the cognate peptide,
giving maximal stimulation at a concentration of 100 nMtherefore the cognate peptide defining the HYAb epitope.
The Dbx homolog of peptide 5 (p5-Dbx-SSSFSSSRASS but causing a significant response at 1 nM. The Dby
peptide 8 equivalent derived from the Dbx sequence,SRSG) did not stimulate (Figure 6A). The binding of p5-
Dby and its Dbx homolog p5-Dbx to H2Ab was tested in REEALHQFRSGKSPI, gave only a low level of stimula-
tion of the HYEk-specific clone at concentrations ofa competition assay using biotinylated CLIP as indicator
peptide. As shown in Figure 6B, p5-Dby and p5-Dbx 100mM, as did Dby peptide 7 (Figure 7).
Figure 5. Role of H2Ab a and b Chains and
Reprocessing by Female BM DCs in the Pre-
sentation of the HYAb Epitope
IL-2 production by the HYAb hybridoma stim-
ulated by COS cell transfectants in the ab-
sence (A) or presence (B) of d6 female BM
DCs.
(A) COS cells transfected with Dby (open cir-
cles); Dby 1 Ii (open triangles); I80-Dby (open
boxes); Dby 1 ab (closed circles); Dby 1 Ii 1 ab
(closed triangles); and I80-Dby 1 ab (closed
boxes).
(B) d6 female BM DCs plus COS cells trans-
fected as in (A). The results represent the
mean and SD of triplicate wells, as in Fig-
ure 3.
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Figure 6. Identification of the Peptide Epi-
tope for HYAb and Demonstration that the Dbx
Homolog of the HYAb Peptide Binds to H2Ab
with the Same Affinity as the Dby Peptide
(A) Stimulation of HYAb clone B9 by candidate
Dby peptides. Peptide 1, p1Dby (open trian-
gles, dotted line): DQQFVGLDKSSDNQ; pep-
tide 2, p2Dby (closed triangles): DKDAYSSFGS
RDSRGK; peptide 3, p3Dby (open boxes):
RPCVVYGGADTVQQIRD; peptide 4, p4Dby
(closed boxes): ARDYRQSSGSANAG; peptide
5, p5Dby (closed circles): NAGFNSNRANS
SRSS; Dbx peptide 5 p5Dbx (open circles, dot-
ted line): SSSFSSSRASSSRSG. Serial 10-fold
dilutions of peptide were tested. The results
give the mean and SD of triplicate wells and
are expressed as dpm. Control responses of
the clone to male and female splenocytes and
to medium alone are shown (open circles).
(B) The peptides representing HYAb epitope
(p5Dby), its Dbx homolog (p5Dbx), and the
four Dby peptides containing the H2Ab bind-
ing motif Dby (p1-p4) as described above
were tested for inhibition of binding of 0.8
mM biotinylated CLIP peptide to purified H2Ab
molecules. The values represent the means
of triplicate wells from a single experiment,
which was repeated twice. The symbols used
are as described in (A).
(C) Stimulation of HYAb clone by substituted
Dby peptides. p5Dby (closed circles): (NAGF
NSNRANSSRSS); p5Dbx (open circles): (SSS
FSSSRASSSRSG); p5-S4 (open boxes): (NAG
FNSSRANSSRSS); P5-S7 (closed boxes): (NAG
FNSNRASSSRSS); p5-S4, S7 (closed triangles):
(NAGFNSSRASSSRSS). Serial 10-fold dilutions
of peptide were tested as in (A).
Discussion shares several core structural elements, including an
Asp-Glu-Ala-Asp (DEAD in single letter code) motif, and
are involved in modulation of secondary and tertiaryThe results presented here describe the MHC class II±
restricted minor H gene as Dby. This gene expresses RNA structure (Fuller-Pace, 1994). They have roles in a
range of cellular processes, including splicing, ribo-two HY determinants, one recognized in association
with H2Ab, the other with H2Ek. Smcy and Uty have been somal assembly, and translation, and may be localized
to the nucleus or cytoplasm. DEAD box proteins fall intoshown to express all the MHC class I±restricted HY
peptide epitopes identified to date (Figure 1 and Simp- two subgroups (Gee and Conboy, 1994). One, including
Dbx (mDEAD3) and Dby (mDEAD2), comprises proteinsson et al., 1997). Although they might, in principle, also
encode those restricted by class II molecules, positional similar to the autosomally encoded mouse testis-spe-
cific PL10 gene (Leroy et al., 1989) and shows extensivemapping of HY, H3, and H13 loci indicate that each
locus is comprised of a gene complex containing at homology around each of six small conserved motifs
within the central core region and a less conserved C-ter-least two genes, separable by recombination or muta-
tion (Roopenian, 1992; King et al., 1994; Roopenian, minal domain, which is rich in Arg, Ser, Gly, and Phe. The
HYAb epitope lies within this distinct C-terminal region of1999). Our finding that the gene encoding the MHC class
II±restricted epitopes, Dby, is separate from but closely Dby. The other group comprises translation initiation
factors including mouse eIF-4AI and eIF-4AII, andlinked to the Smcy and Uty genes provides direct evi-
dence that this is the case. mDEAD5, which all contain a novel peptide motif of 19
amino acids.The specific cellular functions of proteins encoded
by the minor H genes are largely unknown. They are The HYAb peptide epitope defined here as NAGFNSN
RANSSRSS has a single aromatic residue, phenylala-heterogeneous: Smcy shares homology with the retino-
blastoma binding protein, RBP2 (Scott et al., 1995), and nine, that is, according to the H2Ab binding motif, the
likely primary anchor residue, P1 (Wall et al., 1994). AsUty belongs to a family of tetratrico repeat proteins
(Greenfield et al., 1996), H3, H13, and H60 are all novel the binding groove of MHC class II molecules typically
accommodates peptides of nine residues in lengthgenes (Mendoza et al., 1997; Malarkannan et al., 1998;
Zuberi et al., 1998; Roopenian, 1999). They are ubiqui- (Stern et al., 1994), the likely ªcoreº sequence of the
HYAb is FNSNRANSS. Notably, the sequence encodedtously transcribed. Dby belongs to a well-conserved
family of genes coding for known or putative RNA heli- by the X homolog Dbx, FSSSRASSS, contains the same
primary anchor residue and two other putative H2Abcases. This family of so-called DEAD box proteins
Immunity
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of MHC class II±restricted minor transplantation anti-
gens, like their class I±restricted counterparts, are the
result of allelic variation, in this case between X and Y
homologs, of the same gene products, which is in con-
trast to the recent findings for class II±restricted tumor
antigens. For example, one is derived from the protein
product of a mutated gene, CDC27, and does not pro-
vide the neo-epitope. Rather, it changes the cellular
localization of the protein, allowing antigenic peptide
fragments derived from CDC27 to be loaded into class
II molecules (Wang et al., 1999a). Another type of unique
class II±restricted tumor epitope is a novel peptide re-
sulting from a fusion gene between the low density lipid
receptor (LDLR) and a fucosyl transferase gene (FUT)
transcribed in an antisense direction following a tumor-
specific chromosomal translocation (Wang et al., 1999b).
However, in these experiments, it is not altogether clear
whether the protein generated following transfection is
presented by the transfectant itself or is taken up by
and represented by T cells. A third recently described
tumor antigen is a neo-epitope created by mutation in
Figure 7. Identification of the Peptide Epitope for HYEk a glycolytic enzyme, TPI (Pieper et al., 1999). This mutant
Stimulation of HYEk T cell clone by Dby peptides. Peptide 1 (closed TPI peptide can sensitize target cells for recognition by
circles, dashed line): DNQNGGGNTESKGRY; peptide 2 (open circles,
class II±restricted tumor-specific CD41 T cells at nano-dotted line): SFGSRDSRGKPNYFSDRGS; peptide 3 (open boxes):
molar concentrations, in contrast to the nonmutatedGRNDYDGIGGRDRTG; peptide 4 (closed boxes): GEALKAMKEN
melanoma-associated tyrosinase epitopes identified inGRYGR; peptide 5 (closed triangles, pointing up): YGGADTVQQIRDL
ERG; peptide 6 (open triangles, pointing up): TQKVVWVEELDKRS; several tumors, which require micromolar amounts of
peptide 7 (open triangles, pointing down): DSLENFLFQERYA; peptide peptide in detection assays (Topalian et al., 1996; Pieper
8 (closed circles, solid line): REEALHQFRSGRKPI; peptide 9 (closed et al., 1999). The HYAb and HYEk peptide epitopes from
triangles, pointing down): GSANAGFNSNRANSSRSS; Dbx peptide
Dby are also active at nanomolar concentrations (Fig-(open circles, solid line): REEALHQFRSGKSPI. Serial 10-fold dilutions
ures 6 and 7), and this may be characteristic of the highlyof peptide were tested for their ability to stimulate the HYEk T cell
sensitive recognition by T cells specific for this type ofclone in the presence if 1 IU/ml recombinant IL-2. The results give the
mean and SD of triplicate wells and are expressed as dpm. transplantation antigen.
Minor H antigens are in general ubiquitously ex-
pressed on normal cells as well as some leukemia cells
(den-Haan et al., 1998; Warren et al., 1999). Their displaycontact residues, alanine at P6 and serine at P9: this
at the cell surface requires that peptide fragments de-could explain very similar affinities of both peptides for
rived from proteins in various cellular compartmentsH2Ab. Sequence differences between the Dby and Dbx
intersect with the MHC biosynthetic pathways. MHCpeptides are at positions P2, P4, and P7, each changing
class I binding peptides follow a well-characterizedfrom asparagine to serine. Positions P4 and P7 are de-
TAP-dependent route before loading into class I mole-scribed as T cell receptor (TCR) contact residues in
cules, and MHC/minor H peptide complex expressionseveral models (Sette et al., 1987; Daniel et al., 1998);
at the cell surface is readily reconstituted in target cells(Garboczi et al., 1996; Garcia et al., 1998). We have found
transfected with genomic or cDNA fragments (De-Plaenby substituting serine for asparagine at positions P4 and
et al., 1988; Boon et al., 1994; Mendoza et al., 1997).P7 that N at P4 is crucial for T cell recognition. P7
This is not the case for class II loading of endogenousappears less critical since substitution of S for N here
peptides, and targeting the peptide products to the righthad little effect on peptide recognition. In the case of
cellular compartment has presented a major problem,the HYEk epitope, REEALHQFRSGRKPI, P1 and P4 are
certainly using model antigens. To overcome this, invari-generally noncharged, P6 often glutamine, asparagine,
ant chain constructs have been incorporated, whereor alanine, and P9 is almost always lysine or arginine.
APC other than dendritic cells or B cells are used, to loadThe core peptide is therefore likely to be LHQFRSGRK.
peptides into class II molecules for T cell recognition.Comparison of the equivalent sequence from Dbx,
Although sometimes cotransfection of the whole Ii mole-LHQFRSGKS, indicates only two amino acid differences,
cule is found to enhance expression of endogenouslya conservative lysine for arginine at position P8 and
expressed transfected genes, on occasion the presenceserine for lysine at P9. This latter substitution is likely
of Ii inhibits antigen expression (Peterson and Miller,to affect the binding of the Dbx peptide since the P9
1990; Long et al., 1994; Armstrong et al., 1997; Zhongpocket comprises of a long hydrophobic tunnel with
et al., 1997). More recently CLIP-substituted invariantglutamic acid at the base and is unlikely to accommo-
chain has been used to facilitate peptide loading intodate the serine residue (Fremont et al., 1996). The finding
MHC class II molecules (van-Bergen et al., 1997; Fujiithat the Dbx peptide gives very low levels of stimulation
et al., 1998; Malcherek et al., 1998). However, the mostat high concentrations (100 mM) is consistent with this
efficient way of targeting endogenously expressedinterpretation.
Our finding that the peptides giving rise to expression genes into the MIIC compartments has been by making
MHC Class II±Restricted HY Epitopes Identified
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fusion genes with the N-terminal 80 amino acids of in- There is a clinical need to manipulate the immune re-
sponse to minor H antigens following bone marrow trans-variant chain (Sanderson et al., 1995). In the experiments
reported here, cotransfection of Ii did not enhance anti- plantation between HLA-identical individuals, to down-
regulate harmful graft versus host (Goulmy et al., 1996),gen presentation, but the fusion constructs I80-HEL and
I80-Dby both gave high levels of expression when trans- and to optimize graft versus leukemia responses. It is
likely that such immunological manipulation will requirefected into COS cells with H2A a and b. Our unexpected
finding that cotransfection of the H2Abab chains was an knowledge both of class II± as well as class I±restricted
minor H epitopes. This paper provides new informa-absolute requirement for the HEL-Ab peptide expression
even in the presence of dendritic cells suggests that the tion about ways to approach identification of the class
II±restricted epitopes, with this end in mind.MHC class II a and b chains perform an additional role
of stabilizing the HEL-Ab peptide within the cell, thus
Experimental Procedurespreventing its further enzymatic cleavage within the cy-
tosol. In contrast, we found that expression of the ªnatu-
Plasmid DNA Constructs
ralº endogenously derived HYAb peptide epitope did not cDNAs encoding Aba and Abb, HEL, and I80-HEL cloned into pcDNA1
require H2Ab ab for expression. Rather, we found that (Invitrogen) were kindly provided by N. Shastri (Department of Mo-
lecular and Cell Biology, University of California, Berkeley). I80-HELin the absence of I80 to direct Dby expression to the
is a fusion construct encoding the first 80 residues of Ii and full-relevant endosomal compartment, COS cells were un-
length HEL (129 amino acids). The full-length Ii cDNA, cloned intoable to process and express the HYAb epitope from the
the EcoRI site of pExV-3 (Miller and Germain, 1986), was obtainedtransfected Dby gene. There was an absolute require-
from A. Sponaas (Institute for Zoology, University of Bonn). The I80
ment for DCs to reprocess the antigen. This suggests region of Ii was subcloned as an EcoRI±HindIII fragment into pBK-
that, more generally, T cell responses in vivo to this type CMV (Stratagene) for construction of Dby fusion constructs. The
full-length Dby cDNA was cloned into the NotI site of pcDNAI forof antigen will be indirect, following processing of donor
expression studies. N-terminal Dby, encoding the first 91 aminoantigens by recipient APCs.
acids of Dby, was prepared by subcloning a 59 BamHI into pcDNA1.The use of dendritic cells as APC may provide an
NX-Dby (encoding amino acids 1±504) was similarly prepared byeffective alternative route following transfection to opti-
subcloning a NotI±XbaI fragment into pcDNA1. C-terminal Dby con-
mize expression of candidate genes or cDNA pools con- structs were prepared by PCR using the oligonucleotide primers
taining genes encoding class II±restricted minor H epi- 59-ACCATGGGACGTTCTAAAAGC-39 (forward) and 59-ACGCTCGA
GTTATCCTCTGTTGTGGCT-39 (reverse). For preparation of I80 C-ter-topes. It is one which makes no assumptions about the
minal Dby, the forward primer was 59-CGCAAGCTTTTCAGTGGAGnormal pathway taken by the protein precursor before
GATTT-39. This was subcloned into pBK-CMVI80 to give the com-generation and loading of the peptideÐit could be en-
pleted fusion construct . To produce full-length I80-Dby, a 59 frag-dogenous, or follow reprocessing and presentation of
ment encoding the first 91 amino acids of Dby was generated by
secreted material, or that derived from dying cells (Be- PCR with primers 59-CCGAAGCTTAGTCAAGTGGCAGCG-39 (for-
van, 1976; Stockinger et al., 1993; Albert et al., 1998a, ward) and 59-CCTGGATCCACTTCCACGAT-39 (reverse). This was
subcloned into pcDNA1 and combined with a 39 BamHI±NotI frag-1998b). Providing a source of autologous or MHC-
ment encoding the remaining 575 residues of the Dby C terminus.matched dendritic cells is available, their use as final
The complete coding sequence of Dby was subcloned into pBK-APC following transient transfection to provide high lev-
CMV-I80. All constructs were sequenced to confirm fidelity of theirels of protein expression obviates the need to ªtailor
translational reading.
makeº recipient cells by transfection of additional mole-
cules such as DR matched for the restriction molecule Cells and Transfections
COS1 cells were a kind gift of J. Dunne, ICRF. The HYAb-specific Tand DM to facilitate peptide loading. This technique
cell hybridoma (B9BW) was from a fusion between the B9 clonecould therefore be used to identify minor H genes recog-
(Simpson and Tomonari, 1989) and the BWCD4 cell line (derivednized by CD41 T cells isolated from bone marrow trans-
from Z.8 [Karttunen et al., 1992] after transfection with CD4, a kindplant (BMT) patients for whom recipient APCs had been
gift from N. Glaichenhaus, CNRS UniversiteÂ de Nice). The HYEk-
stored before transplantation, as is the practice for specific clone, R2.2, derived from transgenic mice expressing the
chronic myelogenous leukemia (CML) patients given TCR a and b chain from the HYEk T cell clone, A1 (Zelenika et al.,
1998), was provided by E. Adams, University of Oxford. CBA/Ca andBMT.
C57BL/6 mice were obtained from OLAC, Oxon, UK. Bone marrowIn addition to serving as an amplification or enabling
dendritic cells were prepared from the femurs and tibias of femalestep during T cell expression cloning for class II±
donor mice and cultured at 2 to 5 3 105/ml in RPMI 1640 mediumrestricted epitopes of minor H antigens, the special qual-
supplemented with 5 3 1025 M 2-mercaptoethanol,10% fetal calf
ities of dendritic cells at different stages of differentia- serum, and 5%±10% GMCSF (supernatant from X63-Ag8 cells) for
tion (Winzler et al., 1997) could be used to present 6 days. DNA (10 mg each construct) was transfected into COS cells
(1 to 2 3 106) by electroporation using a BioRad Gene Pulser appara-individual minor H peptides in vivo to facilitate induction
tus as described previously (Scott et al., 1992). The cells were resus-of tolerance or immunity. From a report of the ability of
pended in DMEM medium and incubated in 6-well plates at 378Cdendritic cells to process and represent a T cell epitope
for 48 hr.
peptide from a transgenic class II chain, Ea, it is clear
that under certain circumstances, tolerogenic signals Screening Transfectants for HY Epitope Expression
can be generated, both in vitro and in vivo (Inaba et al., After 48 hr, COS cell transfectants were harvested using a rubber
policeman and resuspended at 5 3 105/ml in RPMI 1640 medium.1998). It is also clear from the work of Waldmann and
Fifty or one hundred microliter triplicate samples of transfectantsCobbold that ªinfectiousº and ªbystanderº tolerance to
were placed in 96-well flat-bottomed plates and 33 2-fold dilutionsminor H antigens can result in the spread of tolerance
were made. BM DCs (50 ml at 5 3 105/ml) were added to the 50 ml
to one set of minor antigens (albeit not identified at the samples and incubated for a further 24 hr. The HY-specific clone
peptide level in these experiments) to others present on (R 2.2) or hybridoma (B9BW) cells were added (1 to 2 3 104/well in
100 ml) to the transfectants (6 DCs) and incubated for 24 hr for thethe same APC (Cobbold et al., 1996; Davies et al., 1996).
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hybridoma and 48 hr for the T clone. For the R2.2 clone, 1 IU rIL- acquire antigen from apoptotic cells and induce class I-restricted
CTLs. Nature 392, 86±89.2/ml was also added. One hundred microliter supernatant was har-
vested from each well and assayed for IL-2 or IFNg respectively. Armstrong, T.D., Clements, V.K., Martin, B.K., Ting, J.P.Y., and Os-
IL-2 production was measured by proliferation using an IL-2-depen- trand, R.S. (1997). Major histocompatibility complex class II-trans-
dent T cell clone. One hundred microliter cells at 105/ml were added fected tumor cells present endogenous antigen and are potent in-
to the supernatants. The cells were incubated at 378C for 40 hr and ducers of tumor-specific immunity. Proc. Natl. Acad. Sci. USA 94,
3H-thymidine was added for the last 12±18 hr of culture. The cells 6886±6891.
were harvested and counted using a Wallac 1205 b plate counter
Bevan, M.J. (1976). Cross-priming for a secondary cytotoxic re-(Wallac Pharmacia, Milton Keynes, UK). The results are expressed
sponse to minor H antigens with H-2 congenic cells which do notas dpm. IFNg was measured by ELISA using XMG1.2 anti-mouse
cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283±1288.IFNg monoclonal antibody (PharMingen International, Becton Dick-
Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strom-inson, UK).
inger, J.L., and Wiley, D.C. (1987a). Structure of the human class I
histocompatibility antigen, HLA-A2. Nature 329, 506±512.Screening Peptides for HY Epitope Expression
Peptides were synthesized using FMOC-protected amino acids Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strom-
and (2-(1-H-Benzotriazol-2-yl)-1,1,3,3-tetramethyluronium hexafluoro- inger, J.L., and Wiley, D.C. (1987b). The foreign antigen binding site
phosphate) (HBTU) activation chemistry. After purification by HPLC, and T cell recognition regions of class I histocompatibility antigens.
the fidelity of synthesis was confirmed by mass spectrometry. Syn- Nature 329, 512±518.
thetic peptides were made up as 1 mM stocks in PBS and filter
Boon, T., Cerottini, J.C., Van-den-Eynde, B., van-der-Bruggen, P.,
sterilized. Serial 10-fold dilutions were made in triplicate. Irradiated
and Van-Pel, A. (1994). Tumor antigens recognized by T lympho-
(30 gy) female splenocytes (5 3 105/well) were added to each well.
cytes. Annu. Rev. Immunol. 12, 337±365.
For HYAb, the T cell clone B9 (2 3 104/well) was added, and the
Cella, M., Sallusto, F., and Lanzavecchia, A. (1997). Origin, matura-cells were incubated for 72 hr. 3H-thymidine was added for the last
tion and antigen presenting function of dendritic cells. Curr. Opin.12±18 hr culture, and the cells harvested and counted as described
Immunol. 9, 10±16.above. For HYEk the R2.2 T cell clone was added (2 3 104/well)
together with 1 IU rIL-2/ml. Forty-eight hours later, 100 ml superna- Cobbold, S.P., Adams, E., Marshall, S.E., Davies, J.D., and Wald-
tant was removed and assayed for IFNg as described above. The mann, H. (1996). Mechanisms of peripheral tolerance and suppres-
cells were then pulsed with 3H-thymidine for 12±18 hr as described sion induced by monoclonal antibodies to CD4 and CD8. Immunol.
above to measure proliferation. The proliferation results are pre- Rev. 149, 5±33.
sented here. Daniel, C., Horvath, S., and Allen, P.M. (1998). A basis for alloreactiv-
ity: MHC helical residues broaden peptide recognition by the TCR.
Peptide Binding Assay Immunity 8, 543±552.
The peptide binding to affinity-purified H2Ab molecules was tested
Davies, J.D., Martin, G., Phillips, J., Marshall, S.E., Cobbold, S.P.,as described before (Harris et al., 1995). Briefly, H2Ab molecules (0.5
and Waldmann, H. (1996). T cell regulation in adult transplantationmM) purified from A20 cells transfected with H2Ab (Jurcevic et al.,
tolerance. J. Immunol. 157, 529±533.1996) were mixed with 0.8 mM of biotinylated CLIP peptide (Ii 104±
119, VSKMRMATPLLMQALP) and 0±1000 mM competitor peptide De-Plaen, E., Lurquin, C., Van-Pel, A., Mariame, B., Szikora, J.P.,
in a total volume of 30 ml of binding buffer (0.1 M sodium citrate, Wolfel, T., Sibille, C., Chomez, P., and Boon, T. (1988). Immunogenic
30 mM octyl glucopyranoside, pH 6.0). After incubation at room (tum-) variants of mouse tumor P815: cloning of the gene of tum-
temperature for 48 hr, the mixture was diluted in blocking buffer antigen P91A and identification of the tum- mutation. Proc. Natl.
(PBS, 5% nonfat dry milk, 0.05% Tween-20), divided into triplicate Acad. Sci. USA 85, 2274±2278.
sets, and transferred to a 96-well microtiter plate precoated with den-Haan, J.M., Sherman, N.E., Blokland, E., Huczko, E., Koning,
anti-H2Ab antibody (AF6±120.1.2, from American Tissue Culture Col- F., Drijfhout, J.W., Skipper, J., Shabanowitz, J., Hunt, D.F., Engel-
lection). After 2 hr incubation, the plates were washed, and the hard, V.H., et al. (1995). Identification of a graft versus host disease-
amount of H2Ab-bound biotinylated peptide was determined colori- associated human minor histocompatibility antigen. Science 268,
metrically using streptavidine-peroxidase (Sigma, Poole, UK). Typi- 1476±1480.
cally, absorbance in the presence of the biotinylated indicator pep-
den-Haan, J.M., Meadows, L.M., Wang, W., Pool, J., Blokland, E.,tide alone was in the range of 0.2±0.4, while the background was
Bishop, T.L., Reinhardus, C., Shabanowitz, J., Offringa, R., Hunt,0.01±0.02. The values are presented as either percent of inhibition
D.F., Engelhard, V.H., and Goulmy, E. (1998). The minor histocom-of the binding of indicator peptide or 50% inhibitory peptide concen-
patibility antigen HA-1: a diallelic gene with a single amino acidtrations (IC50) calculated from regression analyses of absorbance
polymorphism. Science 279, 1054±1057.values.
Ehrmann, I.E., Ellis, P.S., Mazeyrat, S., Duthie, S., Brockdorff, N.,
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